News from keryx biopharmaceuticals, inc

Jan 22, 2014, 19:42 ET

Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced the pricing of an underwritten public offering of common stock consisting of...

Jan 21, 2014, 16:19 ET

Keryx Biopharmaceuticals, Inc. Announces $90 Million Proposed Public Offering of Common Stock

 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that it has commenced a $90 million underwritten public offering of shares of...

Jan 17, 2014, 08:00 ET

Keryx Biopharmaceuticals Announces Marketing Approval of Ferric Citrate in Japan

 Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) today announced that its Japanese partner, Japan Tobacco Inc. (JT), has received manufacturing...

Aug 08, 2013, 08:30 ET

Keryx Biopharmaceuticals Announces New Drug Application Submission for Zerenex™ for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis

Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug...

Jun 03, 2013, 08:30 ET

Keryx Biopharmaceuticals, Inc. Announces Zerenex™ Phase 3 Data Presented at the 2013 World Congress of Nephrology

 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced the presentation of updated efficacy and safety data from the Phase 3 long-term...

May 07, 2013, 16:30 ET

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of...

May 06, 2013, 16:30 ET

Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2013 Financial Results

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of...

Mar 14, 2013, 08:56 ET

Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the...

Mar 13, 2013, 08:30 ET

Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of...

Mar 11, 2013, 16:30 ET

Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of...

Mar 11, 2013, 08:30 ET

Keryx Biopharmaceuticals, Inc. To Host Conference Call on Fourth Quarter and Year-End 2012 Financial Results

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of...

Feb 22, 2013, 08:30 ET

Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the...

Feb 08, 2013, 08:30 ET

Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the...

Jan 30, 2013, 22:11 ET

Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced the pricing of its previously announced underwritten public offering of common...

Jan 29, 2013, 16:26 ET

Keryx Biopharmaceuticals Announces $55 Million Proposed Public Offering of Common Stock

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced that it has commenced a $55 million underwritten public offering of shares of its...

Jan 28, 2013, 07:00 ET
Jan 27, 2013, 18:15 ET

Keryx Biopharmaceuticals to Hold Conference Call Tomorrow at 8:00 AM ET to Discuss Top-Line Results from Zerenex™ Phase 3 Long-Term Study

 Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) will host a conference call tomorrow, Monday, January 28, at 8:00am ET to review the top-line...

Jan 07, 2013, 16:30 ET

Keryx Biopharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the...

Jan 07, 2013, 08:00 ET

Keryx Biopharmaceuticals Announces Filing of New Drug Application for Marketing Approval of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco Inc.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) today announced that its Japanese partner, Japan Tobacco Inc. (JT), has filed its New Drug Application...

Jan 03, 2013, 08:30 ET

Keryx Biopharmaceuticals Announces that Congress Delays Implementation of Oral-Only ESRD-Related Drugs, Including Phosphate Binders, in the Bundled ESRD Prospective Payment System by Two-Years, until January 2016

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that earlier this week Congress passed legislation known as the American Taxpayer...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge